Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 19

Citing Papers

Multidrug-resistant Gram-negative bacterial infections
2025 Standout
Cefepime–Taniborbactam in Complicated Urinary Tract Infection
2024 Standout
18 intermediate papers

Works of Jan Pachl being referenced

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial
2017
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
2016

Author Peers

Author Last Decade Papers Cites
Jan Pachl 170 100 491 493 407 23 1.4k
Wolfgang A. Krueger 128 188 538 307 342 43 1.5k
Rosario Amaya‐Villar 213 130 585 313 167 46 1.7k
Lidia Dalfino 396 42 416 365 307 44 1.4k
Claire Dahyot‐Fizelier 323 95 443 199 456 55 1.6k
Hassan Gandjini 180 140 352 499 371 14 1.1k
Jean‐Marie Conil 161 68 332 250 460 66 1.1k
Antonio Corcione 310 59 245 343 255 50 1.1k
Fotini Fligou 180 139 325 493 215 59 1.2k
Adi Lador 200 75 516 285 255 43 1.2k
Daniel Haverstock 167 69 704 217 401 38 1.4k

All Works

Loading papers...

Rankless by CCL
2026